Plasma resistin concentration determined by common variants in the resistin gene and associated with metabolic traits in an aged Japanese population

H. Asano, Hideo Izawa, K. Nagata, M. Nakatochi, M. Kobayashi, A. Hirashiki, S. Shintani, T. Nishizawa, D. Tanimura, K. Naruse, T. Matsubara, T. Murohara, M. Yokota

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Aims/hypothesis: Resistin is a cytokine derived from adipose tissue and is implicated in obesity-related insulin resistance and type 2 diabetes mellitus. Polymorphisms of the resistin gene (RETN) have been shown to affect the plasma resistin concentration. The aims of this study were to identify polymorphisms of RETN that influence plasma resistin concentration and to clarify the relation between plasma resistin level and metabolic disorders in an aged Japanese cohort. Methods: The study participants comprised 3133 individuals recruited to a population-based prospective cohort study (KING study). Plasma resistin concentration, BMI, abdominal circumference, blood pressure, fasting plasma glucose and serum insulin concentrations, HbA1c content and serum lipid profile were measured in all participants. The HOMA index of insulin resistance (HOMA-IR) was also calculated. Eleven polymorphisms of RETN were genotyped. Results: A combination of ANOVA and multiple linear regression analysis in screening and large-scale subsets of the study population revealed that plasma resistin concentration was significantly associated with rs34861192 and rs3745368 polymorphisms of RETN. Multiple linear regression analysis with adjustment for age and sex also showed that the plasma resistin level was significantly associated with serum concentrations of HDL-cholesterol, triacylglycerol and insulin, as well as with BMI. Conclusions/interpretation: Our results implicate the rs34861192 and rs3745368 polymorphisms of RETN as robust and independent determinants of plasma resistin concentration in the study population. In addition, plasma resistin level was associated with dyslipidaemia, serum insulin concentration and obesity. Trial registration: ClinicalTrials.gov NCT00262691 Funding: This study was supported by Grants-in-Aids for Scientific Research from the Japan Society for the Promotion of Science and the Ministry of Education, Culture, Sports, Science, and Technology of Japan.

Original languageEnglish
Pages (from-to)234-246
Number of pages13
JournalDiabetologia
Volume53
Issue number2
DOIs
Publication statusPublished - 01-02-2010

Fingerprint

Resistin
Population
Genes
Insulin
Serum
Insulin Resistance
Linear Models
Japan
Obesity
Regression Analysis
Organized Financing
Dyslipidemias

All Science Journal Classification (ASJC) codes

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Asano, H. ; Izawa, Hideo ; Nagata, K. ; Nakatochi, M. ; Kobayashi, M. ; Hirashiki, A. ; Shintani, S. ; Nishizawa, T. ; Tanimura, D. ; Naruse, K. ; Matsubara, T. ; Murohara, T. ; Yokota, M. / Plasma resistin concentration determined by common variants in the resistin gene and associated with metabolic traits in an aged Japanese population. In: Diabetologia. 2010 ; Vol. 53, No. 2. pp. 234-246.
@article{ce058e0fb90b4c4a898c6e2b7a0e4479,
title = "Plasma resistin concentration determined by common variants in the resistin gene and associated with metabolic traits in an aged Japanese population",
abstract = "Aims/hypothesis: Resistin is a cytokine derived from adipose tissue and is implicated in obesity-related insulin resistance and type 2 diabetes mellitus. Polymorphisms of the resistin gene (RETN) have been shown to affect the plasma resistin concentration. The aims of this study were to identify polymorphisms of RETN that influence plasma resistin concentration and to clarify the relation between plasma resistin level and metabolic disorders in an aged Japanese cohort. Methods: The study participants comprised 3133 individuals recruited to a population-based prospective cohort study (KING study). Plasma resistin concentration, BMI, abdominal circumference, blood pressure, fasting plasma glucose and serum insulin concentrations, HbA1c content and serum lipid profile were measured in all participants. The HOMA index of insulin resistance (HOMA-IR) was also calculated. Eleven polymorphisms of RETN were genotyped. Results: A combination of ANOVA and multiple linear regression analysis in screening and large-scale subsets of the study population revealed that plasma resistin concentration was significantly associated with rs34861192 and rs3745368 polymorphisms of RETN. Multiple linear regression analysis with adjustment for age and sex also showed that the plasma resistin level was significantly associated with serum concentrations of HDL-cholesterol, triacylglycerol and insulin, as well as with BMI. Conclusions/interpretation: Our results implicate the rs34861192 and rs3745368 polymorphisms of RETN as robust and independent determinants of plasma resistin concentration in the study population. In addition, plasma resistin level was associated with dyslipidaemia, serum insulin concentration and obesity. Trial registration: ClinicalTrials.gov NCT00262691 Funding: This study was supported by Grants-in-Aids for Scientific Research from the Japan Society for the Promotion of Science and the Ministry of Education, Culture, Sports, Science, and Technology of Japan.",
author = "H. Asano and Hideo Izawa and K. Nagata and M. Nakatochi and M. Kobayashi and A. Hirashiki and S. Shintani and T. Nishizawa and D. Tanimura and K. Naruse and T. Matsubara and T. Murohara and M. Yokota",
year = "2010",
month = "2",
day = "1",
doi = "10.1007/s00125-009-1517-2",
language = "English",
volume = "53",
pages = "234--246",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer Verlag",
number = "2",

}

Asano, H, Izawa, H, Nagata, K, Nakatochi, M, Kobayashi, M, Hirashiki, A, Shintani, S, Nishizawa, T, Tanimura, D, Naruse, K, Matsubara, T, Murohara, T & Yokota, M 2010, 'Plasma resistin concentration determined by common variants in the resistin gene and associated with metabolic traits in an aged Japanese population', Diabetologia, vol. 53, no. 2, pp. 234-246. https://doi.org/10.1007/s00125-009-1517-2

Plasma resistin concentration determined by common variants in the resistin gene and associated with metabolic traits in an aged Japanese population. / Asano, H.; Izawa, Hideo; Nagata, K.; Nakatochi, M.; Kobayashi, M.; Hirashiki, A.; Shintani, S.; Nishizawa, T.; Tanimura, D.; Naruse, K.; Matsubara, T.; Murohara, T.; Yokota, M.

In: Diabetologia, Vol. 53, No. 2, 01.02.2010, p. 234-246.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Plasma resistin concentration determined by common variants in the resistin gene and associated with metabolic traits in an aged Japanese population

AU - Asano, H.

AU - Izawa, Hideo

AU - Nagata, K.

AU - Nakatochi, M.

AU - Kobayashi, M.

AU - Hirashiki, A.

AU - Shintani, S.

AU - Nishizawa, T.

AU - Tanimura, D.

AU - Naruse, K.

AU - Matsubara, T.

AU - Murohara, T.

AU - Yokota, M.

PY - 2010/2/1

Y1 - 2010/2/1

N2 - Aims/hypothesis: Resistin is a cytokine derived from adipose tissue and is implicated in obesity-related insulin resistance and type 2 diabetes mellitus. Polymorphisms of the resistin gene (RETN) have been shown to affect the plasma resistin concentration. The aims of this study were to identify polymorphisms of RETN that influence plasma resistin concentration and to clarify the relation between plasma resistin level and metabolic disorders in an aged Japanese cohort. Methods: The study participants comprised 3133 individuals recruited to a population-based prospective cohort study (KING study). Plasma resistin concentration, BMI, abdominal circumference, blood pressure, fasting plasma glucose and serum insulin concentrations, HbA1c content and serum lipid profile were measured in all participants. The HOMA index of insulin resistance (HOMA-IR) was also calculated. Eleven polymorphisms of RETN were genotyped. Results: A combination of ANOVA and multiple linear regression analysis in screening and large-scale subsets of the study population revealed that plasma resistin concentration was significantly associated with rs34861192 and rs3745368 polymorphisms of RETN. Multiple linear regression analysis with adjustment for age and sex also showed that the plasma resistin level was significantly associated with serum concentrations of HDL-cholesterol, triacylglycerol and insulin, as well as with BMI. Conclusions/interpretation: Our results implicate the rs34861192 and rs3745368 polymorphisms of RETN as robust and independent determinants of plasma resistin concentration in the study population. In addition, plasma resistin level was associated with dyslipidaemia, serum insulin concentration and obesity. Trial registration: ClinicalTrials.gov NCT00262691 Funding: This study was supported by Grants-in-Aids for Scientific Research from the Japan Society for the Promotion of Science and the Ministry of Education, Culture, Sports, Science, and Technology of Japan.

AB - Aims/hypothesis: Resistin is a cytokine derived from adipose tissue and is implicated in obesity-related insulin resistance and type 2 diabetes mellitus. Polymorphisms of the resistin gene (RETN) have been shown to affect the plasma resistin concentration. The aims of this study were to identify polymorphisms of RETN that influence plasma resistin concentration and to clarify the relation between plasma resistin level and metabolic disorders in an aged Japanese cohort. Methods: The study participants comprised 3133 individuals recruited to a population-based prospective cohort study (KING study). Plasma resistin concentration, BMI, abdominal circumference, blood pressure, fasting plasma glucose and serum insulin concentrations, HbA1c content and serum lipid profile were measured in all participants. The HOMA index of insulin resistance (HOMA-IR) was also calculated. Eleven polymorphisms of RETN were genotyped. Results: A combination of ANOVA and multiple linear regression analysis in screening and large-scale subsets of the study population revealed that plasma resistin concentration was significantly associated with rs34861192 and rs3745368 polymorphisms of RETN. Multiple linear regression analysis with adjustment for age and sex also showed that the plasma resistin level was significantly associated with serum concentrations of HDL-cholesterol, triacylglycerol and insulin, as well as with BMI. Conclusions/interpretation: Our results implicate the rs34861192 and rs3745368 polymorphisms of RETN as robust and independent determinants of plasma resistin concentration in the study population. In addition, plasma resistin level was associated with dyslipidaemia, serum insulin concentration and obesity. Trial registration: ClinicalTrials.gov NCT00262691 Funding: This study was supported by Grants-in-Aids for Scientific Research from the Japan Society for the Promotion of Science and the Ministry of Education, Culture, Sports, Science, and Technology of Japan.

UR - http://www.scopus.com/inward/record.url?scp=77949272381&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949272381&partnerID=8YFLogxK

U2 - 10.1007/s00125-009-1517-2

DO - 10.1007/s00125-009-1517-2

M3 - Article

C2 - 19727657

AN - SCOPUS:77949272381

VL - 53

SP - 234

EP - 246

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - 2

ER -